Journal
EMBO REPORTS
Volume 18, Issue 5, Pages 797-808Publisher
WILEY
DOI: 10.15252/embr.201643270
Keywords
Smad7; TGF-beta; USP26
Categories
Funding
- National Research Foundation Singapore
- Singapore Ministry of Education under its Research Centres of Excellence initiative
- Koninklijke Philips N.V
- Ministry of Education Academic Research Fund Tier 1 grants
Ask authors/readers for more resources
The amplitude of transforming growth factor-beta (TGF-beta) signal is tightly regulated to ensure appropriate physiological responses. As part of negative feedback loop SMAD7, a direct transcriptional target of downstream TGF-beta signaling acts as a scaffold to recruit the E3 ligase SMURF2 to target the TGF-beta receptor complex for ubiquitin-mediated degradation. Here, we identify the deubiquitinating enzyme USP26 as a novel integral component of this negative feedback loop. We demonstrate that TGF-beta rapidly enhances the expression of USP26 and reinforces SMAD7 stability by limiting the ubiquitin-mediated turnover of SMAD7. Conversely, knockdown of USP26 rapidly degrades SMAD7 resulting in TGF-beta receptor stabilization and enhanced levels of p-SMAD2. Clinically, loss of USP26 correlates with high TGF-beta activity and confers poor prognosis in glioblastoma. Our data identify USP26 as a novel negative regulator of the TGF-beta pathway and suggest that loss of USP26 expression may be an important factor in glioblastoma pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available